Release Date: 10/01/12 08:33 Summary: Unsolicited Approach Price Sensitive: Yes Download Document 52.35KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%